<Document id="0002666" source="ADAM" url="https://www.nlm.nih.gov/medlineplus/ency/article/003454.htm">
 
<Focus>Mononucleosis spot test</Focus>
<FocusAnnotations>
	<Category>Disease</Category>
	<UMLS>
		<CUIs>
			<CUI>C0021345</CUI>
		</CUIs>
		<SemanticTypes>
			<SemanticType>T047</SemanticType>
		</SemanticTypes>
		<SemanticGroup>Disorders</SemanticGroup>
	</UMLS>
	<Synonyms>
		<Synonym>Monospot test</Synonym>
		<Synonym>Heterophile antibody test</Synonym>
		<Synonym>Heterophile agglutination test</Synonym>
		<Synonym>Paul-Bunnell test</Synonym>
		<Synonym>Forssman antibody test</Synonym>
	</Synonyms>
</FocusAnnotations>
<QAPairs>
	<QAPair pid="1">
			<Question qid="0002666-1" qtype="information">What is (are) Mononucleosis spot test ?</Question>
			<Answer>The mononucleosis spot test looks for 2  antibodies  in the blood. These antibodies appear during or after an infection with the virus that causes mononucleosis, or mono.</Answer>
	</QAPair>
	<QAPair pid="8">
			<Question qid="0002666-8" qtype="susceptibility">Who is at risk for Mononucleosis spot test? ?</Question>
			<Answer>No information found.</Answer>
	</QAPair>
</QAPairs>
</Document>